Cart (0 Items)
Your cart is currently empty.
View Products
              
              
              
              | Size | 100ug, 1MG  | 
		
|---|---|
| Isotype | IgG1, kappa  | 
		
| Brand | ProteoGenix  | 
		
| Product type | Primary Antibodies  | 
		
| Clonality | Monoclonal Antibody  | 
		
| Expression system | Mammalian cells  | 
		
| Applications | Elisa, WB  | 
		
| Product name | Clazakizumab Biosimilar - Anti-IL6 mAb - Research Grade | 
|---|---|
| Source | CAS 1236278-28-6 | 
| Species | Humanized | 
| Expression system | Mammalian cells | 
| Purity | >85% | 
| Buffer | PBS buffer PH7.5 | 
| Delivery condition | Blue ice (+4°C) | 
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed | 
| Storage condition | store at -80°C | 
| Brand | ProteoGenix | 
| Aliases /Synonyms | Clazakizumab,ALD-518,BMS-945429,IL6,anti-IL6 | 
| Reference | PX-TA1288 | 
| Note | For research use only. Not suitable for clinical or therapeutic use. | 
| Isotype | IgG1-kappa | 
| Clonality | Monoclonal Antibody | 
Clazakizumab has been investigated the treatment of Rheumatoid Arthritis.
                Immobilized Human IL6 recombinant protein (Met 1~Met212) (cat. No.PX-P5129) at 0.5µg/mL (100µL/well) can bind to Clazakizumab Biosimilar - Anti-IL6 mAb (cat. No.PX-TA1288) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450
Related products
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.